Ultra-processed foods: a fit-for-purpose concept for nutrition policy activities to tackle unhealthy and unsustainable diets.


Journal

Public health nutrition
ISSN: 1475-2727
Titre abrégé: Public Health Nutr
Pays: England
ID NLM: 9808463

Informations de publication

Date de publication:
07 2023
Historique:
medline: 12 7 2023
pubmed: 15 12 2022
entrez: 14 12 2022
Statut: ppublish

Résumé

Modern nutrition science began approximately 100 years ago in the context of nutrient deficiency diseases. Nutrition research and policy activities were framed mostly within a reductionist paradigm in which foods were analysed as being a collection of their constituent nutrients. Today, nutrition problems extend to all forms of malnutrition as well as environmental sustainability considerations and are associated with food and dietary pattern exposures. In 2009, researchers investigating the nutrition transition in Brazil proposed that industrial food processing was a key determinant of nutrition problems. The NOVA food classification system which is based on the nature, extent and purposes of food processing was developed to operationalise this proposition. The ultra-processed food (UPF) concept within NOVA is receiving much attention in relation to nutrition research and policy activities. This commentary describes the UPF concept as being fit-for-purpose in providing guidance to inform policy activities to tackle unhealthy and unsustainable diets. There is now a substantial body of evidence linking UPF exposure with adverse population and planetary health outcomes. The UPF concept is increasingly being used in the development of food-based dietary guidelines and nutrition policy actions. It challenges many conventional nutrition research and policy activities as well as the political economy of the industrial food system. Inevitably, there are politicised debates associated with UPF and it is apparent a disproportionate number of articles claiming the concept is controversial originate from a small number of researchers with declared associations with UPF manufacturers. Prominent examples of these claims are assessed.

Identifiants

pubmed: 36514810
pii: S1368980022002117
doi: 10.1017/S1368980022002117
pmc: PMC10346040
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1384-1388

Références

Public Health Nutr. 2019 Apr;22(5):936-941
pubmed: 30744710
Adv Nutr. 2022 Jun 1;13(3):726-738
pubmed: 35325028
BMJ. 2020 Jun 26;369:m2391
pubmed: 32591348
Nutrients. 2023 Jun 26;15(13):
pubmed: 37447216
Asia Pac J Clin Nutr. 2022 Mar;31(1):1-15
pubmed: 35357098
BMJ. 2018 Jun 13;361:k2392
pubmed: 29899124
Lancet Planet Health. 2020 Oct;4(10):e437-e438
pubmed: 33038314
Am J Clin Nutr. 2022 Dec 19;116(6):1482-1488
pubmed: 35670128
Circulation. 2021 Dec 7;144(23):e472-e487
pubmed: 34724806
Rev Saude Publica. 2021 Apr 14;55:13
pubmed: 33886951
Obes Rev. 2020 Dec;21(12):e13126
pubmed: 32761763
Curr Dev Nutr. 2020 Nov 25;4(12):nzaa168
pubmed: 33344879
Public Health Nutr. 2019 Apr;22(5):912-926
pubmed: 30816085
BMJ Glob Health. 2021 Jul;6(7):
pubmed: 34321237
Cell Metab. 2019 Jul 2;30(1):67-77.e3
pubmed: 31105044
Lancet Gastroenterol Hepatol. 2022 Dec;7(12):1128-1140
pubmed: 35952706
Adv Nutr. 2014 Jul 14;5(4):430-46
pubmed: 25022992
Nutrients. 2019 Feb 28;11(3):
pubmed: 30823494
Am J Clin Nutr. 2022 Jun 7;115(6):1646-1657
pubmed: 35470855
Ann Nutr Metab. 2020;76(2):109-113
pubmed: 32344405
Eur J Clin Nutr. 2022 Sep;76(9):1245-1253
pubmed: 35314769
Public Health Nutr. 2009 Aug;12(8):1305
pubmed: 19570304
Obes Rev. 2021 Mar;22(3):e13146
pubmed: 33167080
Proc Nutr Soc. 2019 Feb;78(1):4-18
pubmed: 30249309
J Nutr Sci. 2021 Sep 16;10:e77
pubmed: 34589209

Auteurs

Mark Lawrence (M)

Institute for Physical Activity and Nutrition (IPAN), Deakin University, Geelong, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH